Gastrointestinal gas bubbles and foam interfaces

Gastrointestinal gas bubbles and foam interfaces represent a physical therapeutic target within the digestive tract, primarily addressed to alleviate symptoms of bloating and flatulence (StatPearls, 2023). These bubbles are formed from swallowed air and the fermentation of food by gut microbiota, often becoming trapped in a viscous liquid or mucus foam that prevents their easy expulsion (NIDDK, 2021). Drugs like simethicone act directly on these interfaces by reducing the surface tension of the bubbles, which facilitates their coalescence into larger, more easily passed gas pockets (PubChem, CID 6433516). This physical mechanism does not involve interaction with traditional biological receptors or enzymes but effectively reduces abdominal pressure and distension. Beyond symptomatic relief, targeting these interfaces is crucial in diagnostic procedures such as endoscopy and ultrasonography, where foam can obscure the view of the mucosal lining (ASGE, 2011). The use of antifoaming agents helps clear the visual field for clinicians, improving the detection of lesions or abnormalities. Consequently, managing the integrity of these gas-liquid interfaces is a standard approach in both clinical gastroenterology and over-the-counter digestive health.

Other names

Intestinal gasGastric foamGas-liquid interfaceGastrointestinal foam

Reduction of surface tension of gas bubbles to facilitate coalescence and expulsion